Explore how claudin-18.2 can transform cancer treatment for gastric and pancreatic tumours using targeted radiotherapy.

Discover the innovative TECHNO platform for full-length gene humanisation, enhancing models for human gene function.

North America held a dominan Market position, capturing more than a 42.7% share, holding USD 0.9 Billion revenue.